CEO McClymont sells 200,000 INDI shares (59.6% of holdings) at $6.01 amid unprofitable operations and -2.9% revenue decline
McClymont Donald, Chief Executive Officer, sold 200,000 shares of indie Semiconductor on 2025-10-15 at $6.01, reducing his holdings by 59.6% from 335.6K to 135.6K shares for total proceeds of $1.2M. This large reduction occurs within a concerning operational backdrop: the company reported net income of $-39.0M against quarterly revenue of $51.6M, and full-year annual revenue growth was -2.9%, indicating both current unprofitability and declining top-line momentum. His same-ticker history at INDI shows 3 prior measurable sells, all of which were well-timed at the 90-day mark (meaning the stock declined after those sales), establishing a pattern of selling ahead of downside moves at this specific ticker. The current stock price of $5.32 is already 9.7% below the 52-week high of $5.89 and trades below the $6.01 transaction price, though this recent 30-day +41.5% surge may reflect recovery from earlier lows or other market dynamics.
CEO Donald McClymont sold 188.7K shares (58.2% of holdings) at $4.01 amid unprofitable operations and negative revenue growth.
CEO Donald McClymont executed a substantial sale of 188,700 shares at $4.01 on 2025-09-22, reducing his position from 324.3K shares to 135.6K shares—a 58.2% reduction. This sale follows recent market weakness (stock is down 27.7% from its 52-week high and down 13.5% over the last 30 days) and occurs within a troubling operational context: the company generated $51.6M in quarterly revenue while reporting a net loss of $39.0M, with annual revenue declining 2.9% year-over-year. The CEO's prior four measured sales at this ticker were all followed by further declines at the 90-day mark (100% well-timed rate), and his cross-ticker track record shows a 100.00% well-timed sell rate at the 90-day horizon, suggesting a consistent pattern of exiting before further deterioration. The large magnitude of this share reduction combined with the company's negative profitability and near-term downward price momentum warrants investor scrutiny.
CEO McClymont sold 150,000 INDI shares (52.5% of holdings) at $3.87; stock down -30.7% from 52-week high amid unprofitable fundamentals.
McClymont's sale of 150,000 shares represents a substantial reduction of his holdings at $3.87, executed as the stock trades -30.7% from its 52-week high of $5.48 and amid ongoing unprofitability (net income of $-39.0M on revenue of $51.6M, with annual revenue contraction of -2.9%). His cross-ticker track record shows a 100.00% well-timed rate on sells (average 90-day return of -15.3%), and his same-ticker history at INDI is even more striking: all 5 prior sells were well-timed, each followed by 90-day declines ranging from -15.5% to -15.9%. The current sale follows this exact pattern—the stock has already declined 15.9% in the 30 days since the transaction. This consistency in pre-decline selling, combined with the company's deteriorating financial position (declining revenue, losses widening), suggests the CEO may be responding to adverse business conditions or outlook; however, the sale's execution within his established timing pattern warrants investor scrutiny of interim results and forward guidance.
INDI CEO McClymont Donald sold 200,000 shares (91.6% of holdings) for $942.5K on 2024-11-12, retaining only 18.4K shares.
Donald McClymont filed 5 separate sales totaling 200,000 shares for $942,500.00 on 2024-11-12, executed at prices ranging from $4.70 to $4.72 (blended average $4.71). This represents a -91.6% reduction of his pre-transaction holdings of 218,351 shares, leaving him with only 18,351 shares. The stock now trades at $4.46, down 3.5% from the transaction prices. The CEO's cross-ticker track record shows 1 prior sell with a 90d well-timed rate of 100.00%, and his one prior sale at INDI (2023-12-07) also achieved negative 90-day returns (-13.0%), indicating past sells preceded stock declines. Against this backdrop, the near-complete liquidation of his position warrants investor scrutiny: the company posted a net loss of $49.7M on $54.0M revenue in the latest quarter and remains unprofitable on a full-year basis, even as annual revenue has grown +101.4%. The combination of a distressed financial profile and a seasoned insider shedding nearly all equity ownership creates a material signal for shareholders to evaluate.
